VS
Compare BMO Equal Weight US Health Care Index ETF (ZHU) vs First Trust NYSE Arca Biotechnology ETF (FBT) to find the best fit for your portfolio. ZHU and FBT provide the same top sector exposures: Healthcare. When evaluating costs, ZHU features a management fee (MER) of 0.35%, compared to 0.15% for FBT. Performance-wise, ZHU has returned 21.45% year-to-date with +$0 M in net flows, whereas FBT is at 34.59% with +$5 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
ZHU
FBT
| AuM | $11.85 M | $8.17 M |
| Management Fees | 0.35% | 0.15% |
| Exp. ratio | 0.40% | 0.71% |
| Tracking Difference | 4.48% | - |
Historical performance and flows
As of October 20, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | ZHU | +4.23% | +12.68% | +21.45% | +23.53% | +42.64% |
FBT | +0.90% | +10.68% | +34.59% | +43.54% | +101.50% | |
| Flows | ZHU | +$0 M | +$0 M | +$0 M | +$0 M | -$6 M |
FBT | +$0 M | +$1 M | +$5 M | +$4 M | +$4 M |
ZHU vs FBT exposure
Countries
ZHU
USA
95.31%
FBT
USA
82.68%
Other
17.32%
Sectors
ZHU
Healthcare
100.00%
FBT
Healthcare
99.86%
As of October 20, 2026
Top 10 Holdings
ZHU
Moderna, Inc.
2.85%
Humana, Inc.
2.32%
Revolution Medicines, Inc.
2.29%
Guardant Health, Inc.
1.92%
Illumina, Inc.
1.87%
Natera, Inc.
1.79%
IQVIA Holdings, Inc.
1.62%
Centene Corp.
1.61%
Baxter International, Inc.
1.60%
Veeva Systems, Inc.
1.53%
FBT
Halozyme Therapeutics, Inc.
4.38%
Regeneron Pharmaceuticals, Inc.
3.84%
NeoGenomics, Inc.
3.83%
Corcept Therapeutics, Inc.
3.82%
Amgen, Inc.
3.74%
BeOne Medicines Ltd.
3.72%
Natera, Inc.
3.68%
Repligen Corp.
3.65%
argenx SE
3.63%
Gilead Sciences, Inc.
3.58%
Diversification
ZHU
Total weight of top 10 holdings out of 79 total
19.39%
FBT
Total weight of top 10 holdings out of 30 total
37.87%
Characteristics
Compare
ZHU
FBT
| Provider | BMO | First Trust |
| Management | Passively managed | Passively managed |
| Benchmark | Solactive Equal Weight US Health Care Canadian Dollar Hedged Total Return Index - CAD | NYSE Arca Biotechnology Total Return Index - USD |
| Replication Method | Direct (Physical) | Other |
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 0.45% | 0.00% |
| Meets ESG criteria | No | No |
| Inception Date | February 15, 2019 | October 30, 2014 |
Frequently asked questions about ZHU and FBT
Which ETF has performed better year to date: ZHU or FBT?
As of October 20, 2026, ZHU has returned 21.45% year to date, while FBT has returned 34.59%. FBT is ahead on YTD performance.
Which ETF is larger by assets under management: ZHU or FBT?
As of October 20, 2026, ZHU manages $11.85 M in assets, while FBT manages $8.17 M. ZHU is the larger fund by AUM.
How are ZHU and FBT managed?
ZHU is passively managed by BMO. It tracks the Solactive Equal Weight US Health Care Canadian Dollar Hedged Total Return Index - CAD benchmark. FBT is passively managed by First Trust. It tracks the NYSE Arca Biotechnology Total Return Index - USD benchmark.
What sectors do ZHU and FBT emphasize?
ZHU is most exposed to Healthcare. FBT is most exposed to Healthcare.
Which ETF is attracting more investor flows: ZHU or FBT?
Year to date, ZHU has seen +$0.00 M in net flows, compared with +$4.83 M for FBT. FBT has attracted more net investor money so far.
How do the fees of ZHU and FBT compare?
ZHU has an expense ratio of 0.40%, while FBT has an expense ratio of 0.71%.
What are the top holdings of ZHU and FBT?
ZHU's largest holdings include Moderna, Inc., Humana, Inc., and Revolution Medicines, Inc.. FBT's top holdings include Halozyme Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., and NeoGenomics, Inc..
Which ETF is more diversified: ZHU or FBT?
ZHU holds 79 securities, while FBT holds 30. On holdings count, ZHU is the more diversified portfolio.
Recent articles about ZHU and FBT
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.